2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
4
Plasma cell
3
Classical hematology
3
CNS
3
Endocrine
2
Sarcoma
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Other
1
Lymphoid
1
Head & Neck
1
Dermatologic
1
Conditions
Lymphoma
2984
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2500
Lymphoma, Non-Hodgkin
2269
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Lymphoma, Follicular
1851
Lymphoma, Large B-Cell, Diffuse
1786
Leukemia
1341
Hodgkin Disease
1293
Lymphoma, Mantle-Cell
1193
Leukemia, Myeloid, Acute
979
Burkitt Lymphoma
958
Multiple Myeloma
867
Lymphoma, B-Cell, Marginal Zone
854
Recurrence
842
Lymphoma, B-Cell
756
Myelodysplastic Syndromes
683
Neoplasms
595
Lymphoma, T-Cell, Cutaneous
543
Waldenstrom Macroglobulinemia
514
Lymphoma, Large-Cell, Immunoblastic
490
Mycosis Fungoides
438
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
415
Lymphoma, Large-Cell, Anaplastic
390
Sezary Syndrome
364
Lymphoma, T-Cell, Peripheral
352
Hematologic Neoplasms
352
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
334
Myeloproliferative Disorders
328
Neoplasms, Plasma Cell
309
Blast Crisis
284
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gaucher Disease
×
Lymphoid
×
Clear all
NCT01586455
2022-10-25
HPDSC
New York Medical College
Phase 1
Completed
43 enrolled